Sanofi and Regeneron announce Kevzara® (Sarilumab) biologics license application resubmission accepted for review by US FDA
admin 1st May 2017 Uncategorised 0Sanofi More: Sanofi and Regeneron announce Kevzara® (Sarilumab) biologics license application resubmission accepted for review by US FDA Source: MDlinx
read more